ResMed (RMD)
(Delayed Data from NYSE)
$211.66 USD
+0.75 (0.36%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $211.79 +0.13 (0.06%) 4:30 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 101 - 120 ( 528 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 11122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Delivering on Production Increases in This Supply Chain Environment, Nicely Done
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 102122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 101122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 10122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 92122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 91122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Raising More Questions on PHG''s Quality Systems
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 9122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 82122
Provider: Stock Traders Daily
Analyst: Research Department